News / Information - Zantac 25 (ranitidine hydrochloride effervescent) EFFERdose Tablets Discontinuation

Jan 28, 2013

0173-0734-00

Effective immediately, GlaxoSmithKline (GSK) will discontinue Zantac 25 (ranitidine hydrochloride effervescent) EFFERdose Tablets.

Zantac_25_Efferdose_Tablets_Discontinuation.pdf